K2 HealthVentures Equity Trust LLC 13D and 13G filings for Neumora Therapeutics, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 4:41 pm Sale | 2025-12-31 | 13G | Neumora Therapeutics, Inc. Common Stock NMRA | K2 HealthVentures Equity Trust LLC | 8,997,035 5.010% | -2,400,275 (-21.06%) | Filing |
| 2025-08-11 4:55 pm Purchase | 2025-05-09 | 13G | Neumora Therapeutics, Inc. Common Stock NMRA | K2 HealthVentures Equity Trust LLC | 11,397,310 6.600% | 11,397,310 (New Position) | Filing |